CAS: 181467-56-1 - 5-{[1-({[(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl]oxy}carbonyl)piperidin-4-yl]amino}pentanoic acid

Formel: C₃₃H₃₈N₄O₈

InChl: InChI=1/C33H38N4O8/c1-3-21-22-15-20(45-32(42)36-13-10-19(11-14-36)34-12-6-5-7-28(38)39)8-9-26(22)35-29-23(21)17-37-27(29)16-25-24(30(37)40)18-44-31(41)33(25,43)4-2/h8-9,15-16,19,34,43H,3-7,10-14,17-18H2,1-2H3,(H,38,39)/t33-/m0/s1

1-Piperidinecarboxylic acid, 4-[(4-carboxybutyl)amino]-, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester

CAS: 181467-56-1

• Formel: C₃₃H₃₈N₄O₈
• Reinheit: 99.59%
• Farbe und Form: Solid
• Molekulargewicht: 618.6768

RPR121056

CAS: 181467-56-1

RPR121056 is a Irinotecan metabolite, which is generated by CYP3A4. Irinotecan is an antineoplastic agent …

• Formel: C₃₃H₃₈N₄O₈
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 618.68

Irinotecan Related Compound(RPR 121056)

CAS: 181467-56-1

• Formel: C₃₃H₃₈N₄O₈
• Molekulargewicht: 618.69

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin

CAS: 181467-56-1

Applications A major metabolite of Irinotecan. References Canal, P., et al.: J. Clin. Oncol., 14, …

• Formel: C₃₃H₃₈N₄O₈
• Farbe und Form: Light Yellow
• Molekulargewicht: 618.6768

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin

CAS: 181467-56-1

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin (APC) is a potent inhibitor of secretory phospholipase A2, which has been shown …

• Formel: C₃₃H₃₈N₄O₈
• Reinheit: Min. 95%
• Molekulargewicht: 618.68 g/mol